Cargando…
Emergence and Spread of B.1.1.7 Lineage in Primary Care and Clinical Impact in the Morbi-Mortality among Hospitalized Patients in Madrid, Spain
In December 2020, UK authorities warned of the rapid spread of a new SARS-CoV-2 variant, belonging to the B.1.1.7 lineage, known as the Alpha variant. This variant is characterized by 17 mutations and 3 deletions. The deletion 69–70 in the spike protein can be detected by commercial platforms, allow...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307589/ https://www.ncbi.nlm.nih.gov/pubmed/34361951 http://dx.doi.org/10.3390/microorganisms9071517 |
_version_ | 1783728084138065920 |
---|---|
author | Martínez-García, Laura Espinel, Marco Antonio Abreu, Melanie González-Alba, José María Gijón, Desirèe McGee, Amaranta Cantón, Rafael Galán, Juan Carlos Aranaz, Jesús |
author_facet | Martínez-García, Laura Espinel, Marco Antonio Abreu, Melanie González-Alba, José María Gijón, Desirèe McGee, Amaranta Cantón, Rafael Galán, Juan Carlos Aranaz, Jesús |
author_sort | Martínez-García, Laura |
collection | PubMed |
description | In December 2020, UK authorities warned of the rapid spread of a new SARS-CoV-2 variant, belonging to the B.1.1.7 lineage, known as the Alpha variant. This variant is characterized by 17 mutations and 3 deletions. The deletion 69–70 in the spike protein can be detected by commercial platforms, allowing its real-time spread to be known. From the last days of December 2020 and over 4 months, all respiratory samples with a positive result for SARS-CoV-2 from patients treated in primary care and the emergency department were screened to detect this variant based on the strategy S gene target failure (SGTF). The first cases were detected during week 53 (2020) and reached >90% of all cases during weeks 15–16 (2021). During this period, the B.1.1.7/SGTF variant spread at a rapid and constant replacement rate of around 30–36%. The probability of intensive care unit admission was twice higher among patients infected by the B.1.1.7/SGTF variant, but there were no differences in death rate. During the peak of the third pandemic wave, this variant was not the most prevalent, and it became dominant when this wave was declining. Our results confirm that the B.1.1.7/SGTF variant displaced other SARS-CoV-2 variants in our healthcare area in 4 months. This displacement has led to an increase in the burden of disease. |
format | Online Article Text |
id | pubmed-8307589 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83075892021-07-25 Emergence and Spread of B.1.1.7 Lineage in Primary Care and Clinical Impact in the Morbi-Mortality among Hospitalized Patients in Madrid, Spain Martínez-García, Laura Espinel, Marco Antonio Abreu, Melanie González-Alba, José María Gijón, Desirèe McGee, Amaranta Cantón, Rafael Galán, Juan Carlos Aranaz, Jesús Microorganisms Article In December 2020, UK authorities warned of the rapid spread of a new SARS-CoV-2 variant, belonging to the B.1.1.7 lineage, known as the Alpha variant. This variant is characterized by 17 mutations and 3 deletions. The deletion 69–70 in the spike protein can be detected by commercial platforms, allowing its real-time spread to be known. From the last days of December 2020 and over 4 months, all respiratory samples with a positive result for SARS-CoV-2 from patients treated in primary care and the emergency department were screened to detect this variant based on the strategy S gene target failure (SGTF). The first cases were detected during week 53 (2020) and reached >90% of all cases during weeks 15–16 (2021). During this period, the B.1.1.7/SGTF variant spread at a rapid and constant replacement rate of around 30–36%. The probability of intensive care unit admission was twice higher among patients infected by the B.1.1.7/SGTF variant, but there were no differences in death rate. During the peak of the third pandemic wave, this variant was not the most prevalent, and it became dominant when this wave was declining. Our results confirm that the B.1.1.7/SGTF variant displaced other SARS-CoV-2 variants in our healthcare area in 4 months. This displacement has led to an increase in the burden of disease. MDPI 2021-07-15 /pmc/articles/PMC8307589/ /pubmed/34361951 http://dx.doi.org/10.3390/microorganisms9071517 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Martínez-García, Laura Espinel, Marco Antonio Abreu, Melanie González-Alba, José María Gijón, Desirèe McGee, Amaranta Cantón, Rafael Galán, Juan Carlos Aranaz, Jesús Emergence and Spread of B.1.1.7 Lineage in Primary Care and Clinical Impact in the Morbi-Mortality among Hospitalized Patients in Madrid, Spain |
title | Emergence and Spread of B.1.1.7 Lineage in Primary Care and Clinical Impact in the Morbi-Mortality among Hospitalized Patients in Madrid, Spain |
title_full | Emergence and Spread of B.1.1.7 Lineage in Primary Care and Clinical Impact in the Morbi-Mortality among Hospitalized Patients in Madrid, Spain |
title_fullStr | Emergence and Spread of B.1.1.7 Lineage in Primary Care and Clinical Impact in the Morbi-Mortality among Hospitalized Patients in Madrid, Spain |
title_full_unstemmed | Emergence and Spread of B.1.1.7 Lineage in Primary Care and Clinical Impact in the Morbi-Mortality among Hospitalized Patients in Madrid, Spain |
title_short | Emergence and Spread of B.1.1.7 Lineage in Primary Care and Clinical Impact in the Morbi-Mortality among Hospitalized Patients in Madrid, Spain |
title_sort | emergence and spread of b.1.1.7 lineage in primary care and clinical impact in the morbi-mortality among hospitalized patients in madrid, spain |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307589/ https://www.ncbi.nlm.nih.gov/pubmed/34361951 http://dx.doi.org/10.3390/microorganisms9071517 |
work_keys_str_mv | AT martinezgarcialaura emergenceandspreadofb117lineageinprimarycareandclinicalimpactinthemorbimortalityamonghospitalizedpatientsinmadridspain AT espinelmarcoantonio emergenceandspreadofb117lineageinprimarycareandclinicalimpactinthemorbimortalityamonghospitalizedpatientsinmadridspain AT abreumelanie emergenceandspreadofb117lineageinprimarycareandclinicalimpactinthemorbimortalityamonghospitalizedpatientsinmadridspain AT gonzalezalbajosemaria emergenceandspreadofb117lineageinprimarycareandclinicalimpactinthemorbimortalityamonghospitalizedpatientsinmadridspain AT gijondesiree emergenceandspreadofb117lineageinprimarycareandclinicalimpactinthemorbimortalityamonghospitalizedpatientsinmadridspain AT mcgeeamaranta emergenceandspreadofb117lineageinprimarycareandclinicalimpactinthemorbimortalityamonghospitalizedpatientsinmadridspain AT cantonrafael emergenceandspreadofb117lineageinprimarycareandclinicalimpactinthemorbimortalityamonghospitalizedpatientsinmadridspain AT galanjuancarlos emergenceandspreadofb117lineageinprimarycareandclinicalimpactinthemorbimortalityamonghospitalizedpatientsinmadridspain AT aranazjesus emergenceandspreadofb117lineageinprimarycareandclinicalimpactinthemorbimortalityamonghospitalizedpatientsinmadridspain |